Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ling

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The AAPS Journal|October 14, 2025
Integrated Population Pharmacokinetic-pharmacodynamic Modeling of HIV Virus-host Infection Dynamics in Patients Undergoing Antiretroviral MonotherapyAlberto Vegas Rodriguez, Nieves Velez de Mendizábal, Yanan Zheng, et al.
Analytical Biochemistry|February 9, 2020
An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizerDeqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, et al.
Genome Biology|December 17, 2005
Ulysses - an application for the projection of molecular interactions across speciesDanielle Kemmer, Yong Huang, Sohrab P Shah, et al.
Journal of Pharmaceutical Sciences|September 18, 2023
Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir AlafenamideAnita Wen, Ann Ran-Ran Qin, Thomas Tarnowski, et al.
Clinical Pharmacokinetics|March 10, 2018
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic ImpairmentErik Mogalian, Diana M Brainard, Anu Osinusi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 18, 2022
The determination of Sulfobutylether β-Cyclodextrin Sodium (SBECD) by LC-MS/MS and its application in remdesivir pharmacokinetics study for pediatric patientsZhengdong Yang, Deqing Xiao, Kah Hiing John Ling, et al.
Clinical Pharmacokinetics|March 30, 2021
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication InhibitorRita Humeniuk, Anita Mathias, Brian J Kirby, et al.
Neuropsychological Rehabilitation|May 14, 2025
Technology to improve mental health after an acquired brain injury? A cohort study of research priorities identified by service users, carers, and healthcare professionals in the context of the COVID-19 pandemicSara Katherine Simblett, Daniel O'Donoghue, Maya Carraro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical DevelopmentJim Zheng, Yan Xin, Jingyu Zhang, et al.
The Journal of Infectious Diseases|January 28, 2025
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 YearsNicolas A Margot, Vamshi Jogiraju, Nina Pennetzdorfer, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The AAPS Journal|October 14, 2025
Integrated Population Pharmacokinetic-pharmacodynamic Modeling of HIV Virus-host Infection Dynamics in Patients Undergoing Antiretroviral MonotherapyAlberto Vegas Rodriguez, Nieves Velez de Mendizábal, Yanan Zheng, et al.
Analytical Biochemistry|February 9, 2020
An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizerDeqing Xiao, Kah Hiing John Ling, Thomas Tarnowski, et al.
Genome Biology|December 17, 2005
Ulysses - an application for the projection of molecular interactions across speciesDanielle Kemmer, Yong Huang, Sohrab P Shah, et al.
Journal of Pharmaceutical Sciences|September 18, 2023
Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and Tenofovir AlafenamideAnita Wen, Ann Ran-Ran Qin, Thomas Tarnowski, et al.
Clinical Pharmacokinetics|March 10, 2018
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic ImpairmentErik Mogalian, Diana M Brainard, Anu Osinusi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 18, 2022
The determination of Sulfobutylether β-Cyclodextrin Sodium (SBECD) by LC-MS/MS and its application in remdesivir pharmacokinetics study for pediatric patientsZhengdong Yang, Deqing Xiao, Kah Hiing John Ling, et al.
Clinical Pharmacokinetics|March 30, 2021
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication InhibitorRita Humeniuk, Anita Mathias, Brian J Kirby, et al.
Neuropsychological Rehabilitation|May 14, 2025
Technology to improve mental health after an acquired brain injury? A cohort study of research priorities identified by service users, carers, and healthcare professionals in the context of the COVID-19 pandemicSara Katherine Simblett, Daniel O'Donoghue, Maya Carraro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 10, 2018
Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical DevelopmentJim Zheng, Yan Xin, Jingyu Zhang, et al.
The Journal of Infectious Diseases|January 28, 2025
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 YearsNicolas A Margot, Vamshi Jogiraju, Nina Pennetzdorfer, et al.
Pageof 6